Recurrent Cardiac Events Driven by Prothrombotic Burden in a Patient Undergoing Lipoprotein Apheresis for High Lp(a) Levels
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 1 (1), 001-005
- https://doi.org/10.29328/journal.hcem.1001001
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Lipoprotein Apheresis in Patients With Maximally Tolerated Lipid-Lowering Therapy, Lipoprotein(a)-Hyperlipoproteinemia, and Progressive Cardiovascular DiseaseCirculation, 2013
- Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk AssessmentDisease Markers, 2013
- Clinical guidelines for testing for heritable thrombophiliaBritish Journal of Haematology, 2010
- Peripheral Arterial Tonometry for Risk Stratification in Men With Coronary Artery DiseaseClinical Cardiology, 2010
- Lipoprotein(a) and coronary disease—moving closer to causalityNature Reviews Cardiology, 2009
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- LDL-apheresis: indications and clinical experience in a tertiary cardiac centreInternational Journal of Clinical Practice, 2007
- Lipoprotein (a) and Venous Thromboembolism in Adults: A Meta-AnalysisThe American Journal of Medicine, 2007
- Lipoprotein(a): A Unique Risk Factor for Cardiovascular DiseaseClinics in Laboratory Medicine, 2006
- Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal modelsClinical Biochemistry, 2004